CompletedPhase 2NCT00348790

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Studying Meningioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwestern University
Principal Investigator
Jeffrey J. Raizer, MD, MD, PHD
Northwestern University
Intervention
vatalanib(drug)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
20062013

Study locations (3)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00348790 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma

← Back to all trials